Option Care Health, Inc. (NASDAQ:OPCH) Expected to Post FY2024 Earnings of $1.19 Per Share

Option Care Health, Inc. (NASDAQ:OPCH) – Analysts at William Blair upped their FY2024 earnings per share estimates for shares of Option Care Health in a note issued to investors on Wednesday, April 24th. William Blair analyst M. Larew now anticipates that the company will post earnings per share of $1.19 for the year, up from their prior estimate of $1.17. The consensus estimate for Option Care Health’s current full-year earnings is $1.13 per share. William Blair also issued estimates for Option Care Health’s Q1 2025 earnings at $0.30 EPS, Q2 2025 earnings at $0.35 EPS, Q4 2025 earnings at $0.41 EPS and FY2025 earnings at $1.43 EPS.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Tuesday, April 23rd. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.22 by $0.04. Option Care Health had a return on equity of 18.92% and a net margin of 6.15%. The company had revenue of $1.15 billion during the quarter, compared to analyst estimates of $1.10 billion. During the same period in the previous year, the business earned $0.21 EPS. Option Care Health’s quarterly revenue was up 12.8% on a year-over-year basis.

A number of other analysts have also weighed in on the company. Jefferies Financial Group upped their price objective on Option Care Health from $36.00 to $38.00 and gave the stock a “buy” rating in a research report on Monday, March 4th. Barrington Research restated an “outperform” rating and issued a $38.00 price objective on shares of Option Care Health in a research note on Wednesday.

Option Care Health Trading Down 2.1 %

OPCH opened at $29.29 on Thursday. Option Care Health has a one year low of $24.23 and a one year high of $35.74. The stock has a market capitalization of $5.09 billion, a PE ratio of 19.27, a P/E/G ratio of 1.74 and a beta of 1.22. The business’s 50 day moving average price is $32.04 and its 200 day moving average price is $31.50. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.33 and a current ratio of 1.77.

Institutional Investors Weigh In On Option Care Health

Several hedge funds and other institutional investors have recently modified their holdings of the stock. New York State Teachers Retirement System grew its position in shares of Option Care Health by 1.4% during the 1st quarter. New York State Teachers Retirement System now owns 120,555 shares of the company’s stock valued at $4,043,000 after buying an additional 1,700 shares during the last quarter. Assenagon Asset Management S.A. grew its position in shares of Option Care Health by 0.9% during the 1st quarter. Assenagon Asset Management S.A. now owns 828,970 shares of the company’s stock valued at $27,804,000 after buying an additional 7,043 shares during the last quarter. Louisiana State Employees Retirement System grew its position in shares of Option Care Health by 2.6% during the 1st quarter. Louisiana State Employees Retirement System now owns 51,000 shares of the company’s stock valued at $1,711,000 after buying an additional 1,300 shares during the last quarter. Norden Group LLC boosted its stake in Option Care Health by 1,043.1% during the 1st quarter. Norden Group LLC now owns 121,592 shares of the company’s stock valued at $4,078,000 after purchasing an additional 110,955 shares during the period. Finally, Lifestyle Asset Management Inc. acquired a new position in Option Care Health during the 1st quarter valued at about $211,000. Institutional investors own 98.05% of the company’s stock.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 35,000 shares of Option Care Health stock in a transaction that occurred on Monday, February 26th. The shares were acquired at an average price of $31.55 per share, for a total transaction of $1,104,250.00. Following the acquisition, the director now owns 269,528 shares of the company’s stock, valued at approximately $8,503,608.40. The acquisition was disclosed in a filing with the SEC, which is available at this link. 0.64% of the stock is owned by company insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.